Wilbert Aronow

Cardiology Division, New York Medical College, United States of America

Wilbert Aronow is currently Adjunct Professor of Geriatrics and Adult Development at Mount Sinai School of Medicine, Clinical Professor of Medicine at New York Medical College, Attending Physician (Cardiology and Geriatrics Divisions) at Westchester Medical Center/New York Medical College, and Director of the Cardiology Clinic at Westchester Medical Center/New York Medical College. Since July, 2004, Professor Aronow has also been Attending Physician in the Division of Pulmonary/Critical Care Medicine at Westchester Medical Center/New York Medical College and Senior Associate Program Director and Research Mentor for the Fellowship Programs at New York Medical College.

Professor Aronow is a Fellow of the following societies: the American Geriatrics Society (Founding Fellow of Western Section), the Society of Geriatric Cardiology, the Gerontological Society of America, the American College of Physicians, the American College of Cardiology, the American Heart Association, the American College of Chest Physicians, and the New York Cardiological Society.

He received an Outstanding Teacher and Researcher of the Year Award from the Housestaff, Department of Medicine, Westchester Medical Center/New York Medical College (2001 through to 2007) and the Outstanding Teacher and Researcher Award from the Cardiology Fellows, Westchester Medical Center/New York Medical College for 2001 through to 2007. He has also received awards from the Society of Geriatric Cardiology, from the Gerontological Society of America, and from New York Medical College. Professor Aronow has been a member of 33 editorial boards of medical journals and a guest editor for five other medical journals.

Any competing interests declared are displayed with individual evaluations.

Faculty Member: Cardiovascular Disorders > Geriatric Cardiology (since 15 November 2005)

All recent recommendations

• 3.0
  Usefulness of hypertensive blood pressure response during a single-stage exercise test to predict long-term outcome in patients with peripheral arterial disease.
  Recommended by Wilbert Aronow
  
• 3.0
  Stage-related effect of statin treatment on the progression of aortic valve sclerosis and stenosis.
  Recommended by Wilbert Aronow
  
• 3.2
  Outcomes of elderly patients aged 80 and over with symptomatic, severe aortic stenosis: impact of patient's choice of refusing aortic valve replacement on survival.
  Recommended by Wilbert Aronow, Alik Sagie
  
• 3.0
  Gender differences in the management and prognosis of myocardial infarction among patients > or = 65 years of age.
  Recommended by Wilbert Aronow
  
• 9.8
  Rhythm control versus rate control for atrial fibrillation and heart failure.
  Recommended by Brian Olshansky with Chirag Sandesara, Wilbert Aronow, Hector Ventura with Anil Verma
  
• 3.0
  Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.
  Recommended by Wilbert Aronow
  
• 3.2
  The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis.
  Recommended by Francesco Maisano with Andrea Blasio, Wilbert Aronow
  
• 10.7
  Treatment of hypertension in patients 80 years of age or older.
  Recommended by Deepak Bhatt with Dharam Kumbhani, Ramachandran S. Vasan, Jerome Fleg, Annemarie Hennessy, Ernesto Schiffrin, Wilbert Aronow, Kazuomi Kario with Joji Ishikawa
  
• 3.0
  Excellent early and late outcomes of aortic valve replacement in people aged 80 and older.
  Recommended by Wilbert Aronow
  
• 3.2
  Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial.
  Recommended by Wilbert Aronow, Wolfgang Schoels
  
• 3.0
  Abdominal aortic aneurysms, increasing infrarenal aortic diameter, and risk of total mortality and incident cardiovascular disease events: 10-year follow-up data from the Cardiovascular Health Study.
  Recommended by Wilbert Aronow
  
• 6.0
  Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease.
  Recommended by Wilbert Aronow
  
• 3.0
  Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis.
  Recommended by Wilbert Aronow
  
• 6.0
  Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.
  Recommended by Wilbert Aronow
  
• 6.6
  Rosuvastatin in older patients with systolic heart failure.
  Recommended by Jerome Fleg, Wilbert Aronow, Melvin Cheitlin
  
• 3.0
  Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis.
  Recommended by Wilbert Aronow
  
• 3.4
  Long-term exposure to air pollution and incidence of cardiovascular events in women.
  Recommended by Ulrike Luderer, Ellen Eisen, Viola Vaccarino, Wilbert Aronow
  
• 6.4
  Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial.
  Recommended by Wilbert Aronow, Wolfgang Schoels
  
• 6.0
  Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).
  Recommended by Wilbert Aronow
  
• 6.0
  The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
  Recommended by Wilbert Aronow
  
• 6.0
  Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study).
  Recommended by Wilbert Aronow
  
• 6.0
  Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
  Recommended by Wilbert Aronow
  
• 3.0
  Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study.
  Recommended by Wilbert Aronow
  
• 3.0
  Comparison of 30-day outcomes in patients <75 years of age versus >or=75 years of age with acute myocardial infarction treated by primary coronary angioplasty.
  Recommended by Wilbert Aronow
  
• 3.0
  Survival in elderly patients with severe aortic stenosis is dramatically improved by aortic valve replacement: Results from a cohort of 277 patients aged > or =80 years.
  Recommended by Wilbert Aronow
  
• 6.0
  Carotid sinus hypersensitivity in asymptomatic older persons: implications for diagnosis of syncope and falls.
  Recommended by Wilbert Aronow
  
• 6.0
  Left ventricular geometry and mortality in patients >70 years of age with normal ejection fraction.
  Recommended by Wilbert Aronow
  
• 6.0
  Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.
  Recommended by Wilbert Aronow
  
• 3.0
  Burden of valvular heart diseases: a population-based study.
  Recommended by Wilbert Aronow
  
• 3.0
  Abdominal obesity is an independent risk factor for chronic heart failure in older people.
  Recommended by Wilbert Aronow
  
• 6.6
  Trends in prevalence and outcome of heart failure with preserved ejection fraction.
  Recommended by Wilbert Aronow, Jerome Fleg, Gary Nicholls
  
• 6.0
  Metabolic syndrome, diabetes, and cardiovascular disease in an elderly Caucasian cohort: the Italian Longitudinal Study on Aging.
  Recommended by Wilbert Aronow
  
• 6.0
  Metabolic syndrome and the risk of cardiovascular disease in older adults.
  Recommended by Wilbert Aronow
  
• 6.0
  Usefulness of aortic root dimension in persons > or = 65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study).
  Recommended by Wilbert Aronow
  
• 6.0
  Statins and mortality among elderly patients hospitalized with heart failure.
  Recommended by Wilbert Aronow
  
• 6.0
  The association of microalbuminuria with clinical cardiovascular disease and subclinical atherosclerosis in the elderly: the Cardiovascular Health Study.
  Recommended by Wilbert Aronow
  
• 6.4
  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
  Recommended by Wilbert Aronow, Guy De Backer
  
• 9.0
  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
  Recommended by Wilbert Aronow
  
• 6.0
  Age- and gender-related ventricular-vascular stiffening: a community-based study.
  Recommended by Wilbert Aronow